Fig. 4
From: Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine

(Patient 2) Fluorescein angiography of both eyes
From: Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine
(Patient 2) Fluorescein angiography of both eyes